President

Dr. Anthony Guiseppi-Elie is a renowned bioengineer whose vision and motivations are deeply rooted in the intersection of engineering, medicine, and life sciences. His work primarily focuses on the development of bioanalytical devices, biosensors, and biomedical engineering applications, aiming to improve human health and advance personalized medicine.

Vision

Guiseppi-Elie's vision centers on bridging the gap between technology and biology to create innovative solutions for healthcare. He envisions a future where biosensors and bioelectronics play a critical role in real-time health monitoring, early disease detection, and targeted therapeutics. His goal is to empower healthcare systems with technologies that enable precision medicine, improve patient outcomes, and reduce healthcare costs.

Motivations

• Improving Human Health: His primary motivation is to develop technologies that can save lives and enhance the quality of life through early detection of diseases and real-time monitoring of physiological conditions.
• Advancing Interdisciplinary Science: Guiseppi-Elie is driven by a passion for integrating engineering principles with biological sciences. He believes in the transformative power of interdisciplinary collaboration to solve complex biomedical challenges.
• Personalized Medicine: He is motivated by the potential to personalize healthcare using biosensors and smart devices that can adapt to an individual's specific health needs.
• Global Impact: With a focus on translational research, Guiseppi-Elie seeks to create technologies that are not only scientifically advanced but also accessible and scalable for diverse populations around the world.
• Mentorship and Education: As an academic leader, he is passionate about mentoring the next generation of bioengineers and inspiring students to pursue innovative research in biotechnology and medicine.

Vice-president / Treasurer

Dr. Khosrow Kashfi is a distinguished researcher in the field of pharmacology and medicinal chemistry, with a focus on cancer prevention and treatment. His vision and motivations are deeply rooted in advancing cancer therapeutics through innovative drug development, particularly leveraging the potential of gaseous signaling molecules like nitric oxide (NO) and hydrogen sulfide (H₂S) in pharmacological applications.

Vision

Dr. Kashfi’s vision is to revolutionize cancer treatment and chemoprevention by developing novel, effective, and less toxic therapeutic agents. He aims to bridge the gap between basic biomedical research and clinical applications, with a strong focus on:

• Targeted cancer therapies that minimize harm to healthy cells.
• Harnessing the power of natural compounds and combining them with cutting-edge pharmaceutical technology.
• Creating multifunctional drugs that address cancer’s complexity by targeting multiple pathways simultaneously.

Motivations

• Combating Cancer: Driven by the global burden of cancer, Dr. Kashfi is motivated to find safer, more effective treatments that can improve survival rates and quality of life for patients.
• Innovative Drug Design: His passion lies in drug discovery and development, especially exploring how gaseous molecules like NO and H₂S can be incorporated into drugs to enhance their therapeutic potential.
• Translational Research:He is committed to translating laboratory discoveries into clinical solutions, ensuring that his research has a real-world impact on patient care.
• Scientific Curiosity: Dr. Kashfi’s work is fueled by a deep curiosity about biological mechanisms and how molecular interventions can alter disease progression, particularly in inflammation and cancer.
•  Mentorship and Leadership: As a researcher and educator, he is motivated to mentor young scientists, fostering a new generation of pharmacologists and researchers who can continue pushing the boundaries of medical science.

Secretary

Mr. Rama Kalagara, a visionary IT leader, blends technology, business, and social impact to democratize knowledge and drive meaningful change through transformative conferences.

Vision

Rama envisions using AI and ML to address real-world challenges and make advanced technology accessible to all. His conferences serve as collaborative platforms where industry leaders, professionals, and students converge to exchange ideas, build partnerships, and advance technology for social good.

Core Principles

• Innovation with Purpose: Showcasing AI and ML solutions to create impactful, scalable event experiences.
• Community Building:Connecting thought leaders and aspiring technologists to foster lasting collaborations.
• Next-Generation Leadership: Empowering emerging talent through mentorship and knowledge sharing.
• Digital Excellence: Leveraging cutting-edge IT architecture for seamless, immersive experiences.

Mission

As a non-profit leader, Rama’s mission is to curate world-class conferences that inspire professional growth, promote knowledge exchange, and drive societal transformation. His focus on inclusivity and innovation ensures that each event creates lasting value and strengthens the global technology community.

Board Member

Dr. Patrícia Rijo is committed to scientific advancement, international collaboration, and public engagement in medicinal chemistry, phytochemistry, and pharmacognosy. With extensive experience in research, networking, and science communication, she aims to foster knowledge exchange, empower young scientists, and drive innovation in natural bioactive products.

Vision

Patrícia Rijo envisions a dynamic, inclusive platform that:

• Promotes global collaboration in natural product chemistry, drug discovery, and ethnopharmacology.
• Empowers young researchers through mentorship, networking, and funding opportunities.
• Bridges academia and industry to foster innovation and technology transfer in pharmaceutical sciences.

Motivations

• Strengthening Scientific Networks: Leveraging her experience in international collaborations (COST Actions, CYTED) to enhance knowledge sharing through structured conferences.
• Encouraging Interdisciplinary Research: Promoting cross-disciplinary approaches in medicinal chemistry, pharmacognosy, and phytochemistry to address health challenges.
• Supporting Young Researchers and Diversity: Advocating for early-career scientists and underrepresented groups through mentorship and inclusion programs.
• Advancing Public Engagement: Using her leadership in science outreach to foster public trust and promote evidence-based decision-making.
• Recognition of Excellence:Committed to high-impact research, recognized among the “World’s Top 2% Scientists” (Stanford University, 2022 & 2023).

Her vision for a non-profit conference organization reflects her mission to advance scientific excellence, empower young talent, and create meaningful societal impact in pharmaceutical sciences.